Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study reveals hidden struggles of immigrant women with breast cancer

NCT ID NCT06503393

Knowledge-focused Sponsor: Institut de Recherche pour le Developpement Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study looked at 470 women with breast cancer in Paris to understand how their background affects their experience. It compared women born in France with those born in sub-Saharan Africa, focusing on diagnosis timing, treatment access, and social impacts. The goal is to improve medical and social care for all women.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

470 people

The number who actually took part.

Started

Mar 2024

Finished

Jul 2025

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Women born in sub-Saharan Africa and in France who have been diagnosed with breast cancer between the 1st of January 2014 and for more than three years at the time of the survey, and visiting four hospitals (Saint-Louis University Hospital AP-HP; Delafontaine Hospital Saint-Denis; Robert Ballanger, Hospital, Aulnay-sous-Bois; Avicenne University Hospital AP-HP) in the greater Paris area.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women aged 18 or more * Women who consult in one of the partner hospitals of the study * For groups 1: women born in a country of sub-Saharan Africa * For group 2: women born in France * Have been diagnosed with breast cancer between the 1st of January 2014 and for more than three years at the time of the survey. Exclusion Criteria: * Does not speak French * Under 18 years old * Have been diagnosed with breast cancer before 2014 and for less than three years at the time of the survey.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm female breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer female

Contacts and locations

Locations

  • Avicenne University Hospital AP-HP

    Bobigny, 93000, France

  • Delafontaine Hospital Saint-Denis

    Saint-Denis, France

  • Robert Ballanger Hospital Aulnay-Sous-Bois

    Aulnay-sous-Bois, France

  • Saint-Louis University Hospital AP-HP

    Paris, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.